Elevation Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8K Buy
76
+29
+62% +$8.02K 0.01% 646
2026
Q1
$13.9K Sell
47
-22
-32% -$6.54K 0.01% 451
2025
Q4
$18.8K Buy
69
+33
+92% +$8.97K 0.01% 383
2025
Q3
$9.73K Buy
36
+11
+44% +$2.99K ﹤0.01% 390
2025
Q2
$6.89K Hold
25
﹤0.01% 388
2025
Q1
$6.63K Hold
25
﹤0.01% 391
2024
Q4
$5.81K Hold
25
﹤0.01% 403
2024
Q3
$5.52K Hold
25
﹤0.01% 388
2024
Q2
$4.92K Sell
25
-1
-4% -$207 ﹤0.01% 385
2024
Q1
$5.6K Buy
26
+1
+4% +$210 ﹤0.01% 386
2023
Q4
$5.01K Hold
25
﹤0.01% 365
2023
Q3
$5.01K Hold
25
﹤0.01% 274
2023
Q2
$4.63K Hold
25
﹤0.01% 283
2023
Q1
$4.79K Buy
+25
New +$4.52K ﹤0.01% 289

Other funds holding CME

Elevation Wealth Partners's CME Position: Q2 2026 in Review

Elevation Wealth Partners increased its CME Group (CME) stake by 62% in Q2 2026, buying an estimated $8.02K and bringing the position to 76 shares worth $16.8K. The position accounts for 0.01% of the portfolio, ranked #646.

Elevation Wealth Partners first reported a position in CME in Q1 2023 and has held it in 14 quarters since. The position peaked at $18.8K in Q4 2025. 593 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Elevation Wealth Partners held 76 shares of CME Group worth $16.8K as of Q2 2026.
  • Elevation Wealth Partners bought 29 CME Group shares in Q2 2026, an estimated $8.02K.
  • CME Group made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #646 holding.
  • Elevation Wealth Partners first reported a position in CME Group in Q1 2023 and has held it in 14 quarters since.
  • Elevation Wealth Partners's CME Group position peaked at $18.8K in Q4 2025.
  • 593 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.